1f8i: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1f8i.gif|left|200px]]
{{Seed}}
[[Image:1f8i.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1f8i|  PDB=1f8i  |  SCENE=  }}  
{{STRUCTURE_1f8i|  PDB=1f8i  |  SCENE=  }}  


'''CRYSTAL STRUCTURE OF ISOCITRATE LYASE:NITROPROPIONATE:GLYOXYLATE COMPLEX FROM MYCOBACTERIUM TUBERCULOSIS'''
===CRYSTAL STRUCTURE OF ISOCITRATE LYASE:NITROPROPIONATE:GLYOXYLATE COMPLEX FROM MYCOBACTERIUM TUBERCULOSIS===




==Overview==
<!--
Isocitrate lyase (ICL) plays a pivotal role in the persistence of Mycobacterium tuberculosis in mice by sustaining intracellular infection in inflammatory macrophages. The enzyme allows net carbon gain by diverting acetyl-CoA from beta-oxidation of fatty acids into the glyoxylate shunt pathway. Given its potential as a drug target against persistent infections, we solved its structure without ligand and in complex with two inhibitors. Covalent modification of an active site residue, Cys 191, by the inhibitor 3-bromopyruvate traps the enzyme in a catalytic conformation with the active site completely inaccessible to solvent. The structure of a C191S mutant of the enzyme with the inhibitor 3-nitropropionate provides further insight into the reaction mechanism.
The line below this paragraph, {{ABSTRACT_PUBMED_10932251}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 10932251 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_10932251}}


==About this Structure==
==About this Structure==
Line 39: Line 43:
[[Category: Tb structural genomics consortium]]
[[Category: Tb structural genomics consortium]]
[[Category: Tbsgc]]
[[Category: Tbsgc]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 16:01:46 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 02:52:05 2008''